AzTrials
AzTrials

FibromyalgiaNCT05907590

Proprioception and Interoception in Patients With Fibromyalgia

An observational study of Fibromyalgia, run by Hasselt University at 2 sites in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn about interoception and proprioception in patients with fibromyalgia. The main questions it aims to answer are: Is there a significant difference in interoception between patients with fibromyalgia and healthy controls? Is there a significant difference in… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Fibromyalgia
What is being tested?
Interoceptive accuracy measurement, Interoceptive sensibility measurement and Interoceptive awareness measurement
How many people
52 participants
Where
2 sitesBelgium
Study dates
25 Jul 2022to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients with fibromyalgia diagnosed according to the ACR criteria (Wolfe et al., 2010; 2016) are eligible to participate

Who may be able to join

  • Healthy controls will be selected so that there is an equal ratio between patients and healthy controls for
  • Age group (per 5 years)
  • Gender (including X)
  • Educational attainment
  • BMI
  • all participants need a score < 75 on the CSD (Walentynowicz et al., 2018)
  • Patients with fibromyalgia diagnosed using the ACR criteria (Wolfe et al., 2010; 2016).

Who cannot join

  • Pregnancy
  • Under the age of 18 or over the age of 65.
  • Presence of a depressive episode, anxiety disorder, eating disorder, substance abuse, neurocognitive, or psychotic disorder diagnosed with DSM-V (Diagnostic and Statistical Manual of Mental Disorders; MINI-s; Overbeek et al., 1999).
  • Presence of a chronic organic disorder (It is referred to as a chronic organic disorder if it has been present for a period of at least 3 months. Examples are: epilepsy, heart disease, rheumatism, asthma, diabetes, etc.) or acute organic disorder (fever, flu, etc.)
  • Persistent physical complaints (e.g. hyperventilation complaints, long-term COVID, chronic pain or fatigue, chronic tinnitus, etc. )
  • Neck complaints at the time of testing
Show all 20Show fewer
  • Recent whiplash trauma less than 3 months ago or more than 3 months ago with complaints still present
  • Diagnosis of vestibular or neurological disorders
  • Recent orthopedic problems of the lower extremities (e.g. acute ankle trauma) that may affect balance
  • BMI>30
  • Eligibility criteria patients with fibromyalgia
  • Pregnancy
  • Under the age of 18 or over the age of 65
  • Primary depressive episode, anxiety disorder, eating disorder, substance abuse, neurocognitive, or psychotic disorder diagnosed with DSM-V (MINI-s; Overbeek et al., 1999).
  • Presence of a chronic organic disorder (It is referred to as a chronic organic disorder if it has been present for a period of at least 3 months. Examples are: epilepsy, heart disease, rheumatism, asthma, diabetes, etc.) or acute organic disorder (fever, flu, etc.)
  • Neck complaints at the time of testing (not related to the current problem)
  • Recent whiplash trauma less than 3 months ago or more than 3 months ago with symptoms still present
  • Diagnosis of organically explained vestibular or neurological disorders
  • Recent orthopedic problems of the lower extremities (e.g., acute ankle trauma) that may affect balance
  • BMI>30

Trial locations and contacts

2 sites in 1 country.

Marleen Missotten contact

+32(0)11268502

CME@uhasselt.be

Belgium2 sites, 2 recruiting
  • Hasselt University

    Diepenbeek, Limburg, 3590

    Indra Ramakers, +32483082723, indra.ramakers@uhasselt.be

    Recruiting
  • TRACE labs Ziekenhuis Oost-Limburg (ZOL)

    Lanaken, Limburg, 3620

    Indra Ramakers, +32483082723, indra.ramakers@uhasselt.be

    Recruiting

Other trials in Belgium

About this study

The goal of this observational study is to learn about interoception and proprioception in patients with fibromyalgia. The main questions it aims to answer are:

  • Is there a significant difference in interoception between patients with fibromyalgia and healthy controls?
  • Is there a significant difference in proprioception between patients with fibromyalgia and healthy controls?
Read more

The participants will perform:

  • The respiratory occlusion discrimination task
  • A postural control task where the effect of muscle vibration on center of gravity displacement is examined
  • The head repositioning accuracy task

The participants will also fill out different questionnaires.

Researchers will compare healthy controls to see if there is a significant difference.

Read the detailed description

Fibromyalgia is a chronic widespread pain condition characterized by point tenderness, fatigue, sleep disturbance, cognitive complaints, and increasing somatic complaints. With this case-control study we want to emphasize the importance of an integrative psychophysiological model for fibromyalgia, in which interoception and proprioception are being investigated.

Interoception has been described in the literature as "the overall process of how the nervous system senses, integrates, stores and displays information about the state of the internal body". Theory suggests that interoception should be divided into three measurable constructs: interoceptive accuracy (objective accuracy in detecting internal bodily sensations), interoceptive sensitivity (the self-perceived tendency to be internally self-focused), and interoceptive awareness (metacognition about his/her own interoceptive accuracy). Proprioception on the other hand, is described as the sense of body position and movement.

The first measurement will take place in the lab of REVAL Hasselt University. First, informed consent will be signed before any data collection takes place. This part of the experiment will take approximately 30 minutes.

Two proprioception tasks will be performed consecutively. The effect of muscle vibration on centre of gravity displacement (center of pressure or COP) will be examined. Muscle vibration of the m. triceps surae ("ankle" muscles) and the lumbar multifidus ("back" muscles) will be used to examine the role of proprioception during postural control. The displacement (magnitude) of the COP during standing will be assessed with a force plate. The muscle vibration induces muscle extension illusions, so that, in order to maintain balance, the subject, by a compensatory mechanism, will send the COP to the opposite side when he or she effectively uses the proprioceptors (muscle spindles) of the vibrated muscle. The same task will be performed on both a stable and an unstable surface.

The head reposition accuracy task will be carried out to assess neck proprioception. The most commonly used procedure is the head repositioning accuracy to neutral head position (HRA-to-NHP). During this procedure, the subject sits against a backrest. The subject is blindfolded to exclude visual input and wears a helmet containing a beam of light directed at a target 90 cm in front of the subject. The subject is instructed to look straight ahead and memorize this position. At that point, the test leader will mark off this point on the target. Subject's head is turned at an angle by the subject (active). Test subject will hereafter have to actively move the head back to the initial position. The direction of movement used are rotations, both to the left and to the right.

The second part of the experiment will take place in the TRACE labs of Ziekenhuis Oost Limburg (ZOL). It will take approximately 30 minutes. Participants will start with the interoceptive accuracy task using the Respiratory Occlusion Discrimination Task (ROD task). The ROD task measures how good subjects are at distinguishing the lengths of short (max 620 milliseconds) inspiratory occlusions (or respiratory interruptions). Occlusions of these lengths are not aversive or unpleasant. One trial consists of two occlusions within one inspiration (inter-occlusion interval = 300 milliseconds), one occlusion being the reference occlusion (always 440 milliseconds) and one occlusion being the test occlusion (longer or shorter than 440 milliseconds), administered in random order. The participant is asked to indicate which of the two occlusions was longest. An adaptive staircase paradigm is thus used to determine the just noticeable difference in lengths of inspiratory occlusions. The length of the task depends on the performance of the subject, but is on average 56 trials (= 15 minutes). After the experiment, another short side experiment of 16 trials will be conducted in which the participant should indicate how confident they were in their response on a Visual Analogue scale (VAS), in order to estimate interoceptive awareness. In the meantime, participants will be also asked to complete a questionnaire bundle at home (online), which takes approximately 45 minutes to complete.

The power calculations resulted in a total of 26 persons per group. Therefore the investigators plan to recruit a total of 52 people.

Primary outcomes are interoceptive accuracy, interoceptive sensibility, interoceptive awareness, and proprioceptive accuracy. Secondary outcome measures are psychological variables measured using questionnaires.

Descriptive statistics will be used to display baseline group characteristics. To evaluate between-group differences (i.e. the difference between patients with fibromyalgia and healthy controls regarding interoception, proprioception and psychological variables) t-tests will be used.

Conditions
Fibromyalgia
Being tested
Interoceptive accuracy measurement, Interoceptive sensibility measurement, Interoceptive awareness measurement, Proprioceptive accuracy measurement during postural control, Proprioceptive accuracy measurement of the neck
Keywords
Interoception, Proprioception, Fibromyalgia
Medical subject headings
Fibromyalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interoceptive accuracy measurementOther

    Interoceptive accuracy will be measured using the Respiratory Occlusion Discrimination Task (ROD task; Van Den Houte et al., 2021). The ROD task measures how good subjects are at distinguishing the lengths of short (max 620 milliseconds) inspiratory occlusions (or respiratory interruptions).

  • Interoceptive sensibility measurementOther

    Interoceptive sensibility will be measured using two self-report questionnaires, the Interoceptive Sensitivity and Attention Questionnaire (ISAQ; Bogaerts et al., 2022) and the the Three-domain Interoceptive Sensations Questionnaire (THISQ; Vlemincx et al., 2021)

  • Interoceptive awareness measurementOther

    Interoceptive awareness will be measures using a visual analogue scale (VAS)

  • Proprioceptive accuracy measurement during postural controlOther

    The effect of muscle vibration on center of gravity displacement (center of pressure or COP) will be examined. Muscle vibration of the m. triceps surae ("ankle" muscles) and the lumbar multifidus ("back" muscles) (Johanson et al., 2011; Brumagne et al., 2008; Claeys et al., 2011; Cleays et al., 2015) will be used to examine the role of proprioception during postural control.

  • Proprioceptive accuracy measurement of the neckOther

    The head reposition accuracy task will be carried out to assess proprioceptive accuracy of the neck. The most commonly used procedure is the head repositioning accuracy to neutral head position (HRA-to-NHP), first described by Revel and colleagues (1991).

Study groups in NCT05907590
Study groupRoleWhat they receive
Patients with FibromyalgiaPatients with fibromyalgia diagnosed using the ACR criteria (American College of Rheumatology, Wolfe et al., 2010; 2016).
Receives: Other: Interoceptive accuracy measurement; Other: Interoceptive sensibility measurement; Other: Interoceptive awareness measurement; Other: Proprioceptive accuracy measurement during postural control; Other: Proprioceptive accuracy measurement of the neck
Healthy ControlsHealthy controls will consist of people who experience few physical complaints in daily life. The healthy controls will thus be screened for inclusion using the CSD (Checklist for Symptoms in Daily life; Walentynowicz, et al., 2018). Only volunteers with a score of 75 or lower on this questionnaire will be included
Receives: Other: Interoceptive accuracy measurement; Other: Interoceptive sensibility measurement; Other: Interoceptive awareness measurement; Other: Proprioceptive accuracy measurement during postural control; Other: Proprioceptive accuracy measurement of the neck

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Interoceptive accuracy

    Respiratory occlusion discrimination task (ROD task; Van Den Houte et al., 2021)

    Measured: 20 minutes

  2. Interoceptive sensibility

    Interoceptive Sensitivity and Attention Questionnaire (ISAQ; Bogaerts et al., 2022)

    Measured: 5 minutes

  3. Interoceptive sensibility

    THree-domain Interoceptive Sensations Questionnaire (THISQ; Vlemincx et al., 2021)

    Measured: 5 minutes

  4. Interoceptive awareness

    Visual analogue scale (0-100). A score of 0 indicates that participants are not certain at all of their answer, a score of 100 indicates that participants are entirely certain of their answer.

    Measured: 5 minutes

  5. Proprioceptive accuracy

    Head repositioning accuracy task

    Measured: 5 minutes

  6. Proprioceptive accuracy

    Postural control task

    Measured: 30 minutes

Secondary outcomes (8)
  1. Psychological variables

    Checklist for Symptoms in Daily Life (CSD; Walentynowicz et al., 2018)

    Checklist for Symptoms in Daily Life (CSD; Walentynowicz et al., 2018)

    Checklist for Symptoms in Daily Life (CSD; Walentynowicz et al., 2018)

    Checklist for Symptoms in Daily Life (CSD; Walentynowicz et al., 2018)

    Measured: 5 minutes

  2. Psychological variables

    Positive and Negative Affect Scale (PANAS; Watson et al., 1988)

    Measured: 5 minutes

  3. Psychological variables

    Tellegen Absorption Scale (TAS; Tellegen \& Atkinson, 1974)

    Measured: 5 minutes

  4. Psychological variables

    Traumatic Experiences Checklist (TEC; Nijenhuis et al., 2002)

    Measured: 10 minutes

  5. Psychological variables

    Toronto Alexithymia Scale (TAS-20; Bagby et al., 1994)

    Measured: 5 minutes

  6. Psychological variables

    Need for Controllability and Predictability Questionnaire (NCP-q; Ramakers et al., manuscript in preparation)

    Measured: 5 minutes

  7. Psychological variables

    Frost Multidimensional Perfectionism Scale (FMPS; Frost et al., 1990)

    Measured: 5 minutes

  8. Psychological variables

    Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011)

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2023
  2. Study start25 Jul 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05907590
Sponsor's protocol ID
B1152022000007
Status last verified
Jun 2023
First submitted
24 May 2023
Last updated
18 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.

    PubMed 20461783
  • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. Epub 2016 Aug 30.

    PubMed 27916278
  • Khalsa SS, Adolphs R, Cameron OG, Critchley HD, Davenport PW, Feinstein JS, Feusner JD, Garfinkel SN, Lane RD, Mehling WE, Meuret AE, Nemeroff CB, Oppenheimer S, Petzschner FH, Pollatos O, Rhudy JL, Schramm LP, Simmons WK, Stein MB, Stephan KE, Van den Bergh O, Van Diest I, von Leupoldt A, Paulus MP; Interoception Summit 2016 participants. Interoception and Mental Health: A Roadmap. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):501-513. doi: 10.1016/j.bpsc.2017.12.004. Epub 2017 Dec 28.

    PubMed 29884281
  • Garfinkel SN, Seth AK, Barrett AB, Suzuki K, Critchley HD. Knowing your own heart: distinguishing interoceptive accuracy from interoceptive awareness. Biol Psychol. 2015 Jan;104:65-74. doi: 10.1016/j.biopsycho.2014.11.004. Epub 2014 Nov 20.

    PubMed 25451381
  • Tuthill JC, Azim E. Proprioception. Curr Biol. 2018 Mar 5;28(5):R194-R203. doi: 10.1016/j.cub.2018.01.064.

    PubMed 29510103
  • Walentynowicz, M., Witthöft, M., Raes, F., Van Diest, I., & Van den Bergh, O. (2018). Sensory and affective components of symptom perception: a psychometric approach. Journal of Experimental Psychopathology, 9(2), 1-13. Doi: 10.5127/jep.059716

  • Brumagne S, Janssens L, Knapen S, Claeys K, Suuden-Johanson E. Persons with recurrent low back pain exhibit a rigid postural control strategy. Eur Spine J. 2008 Sep;17(9):1177-84. doi: 10.1007/s00586-008-0709-7. Epub 2008 Jul 2.

    PubMed 18594876
  • Claeys K, Brumagne S, Dankaerts W, Kiers H, Janssens L. Decreased variability in postural control strategies in young people with non-specific low back pain is associated with altered proprioceptive reweighting. Eur J Appl Physiol. 2011 Jan;111(1):115-23. doi: 10.1007/s00421-010-1637-x. Epub 2010 Sep 8.

    PubMed 20824281
  • Claeys K, Dankaerts W, Janssens L, Pijnenburg M, Goossens N, Brumagne S. Young individuals with a more ankle-steered proprioceptive control strategy may develop mild non-specific low back pain. J Electromyogr Kinesiol. 2015 Apr;25(2):329-38. doi: 10.1016/j.jelekin.2014.10.013. Epub 2014 Oct 31.

    PubMed 25467548
  • Johanson E, Brumagne S, Janssens L, Pijnenburg M, Claeys K, Paasuke M. The effect of acute back muscle fatigue on postural control strategy in people with and without recurrent low back pain. Eur Spine J. 2011 Dec;20(12):2152-9. doi: 10.1007/s00586-011-1825-3. Epub 2011 May 1.

    PubMed 21533851
  • Cordo PJ, Gurfinkel VS, Brumagne S, Flores-Vieira C. Effect of slow, small movement on the vibration-evoked kinesthetic illusion. Exp Brain Res. 2005 Dec;167(3):324-34. doi: 10.1007/s00221-005-0034-x. Epub 2005 Aug 20.

    PubMed 16132974
  • Revel M, Andre-Deshays C, Minguet M. Cervicocephalic kinesthetic sensibility in patients with cervical pain. Arch Phys Med Rehabil. 1991 Apr;72(5):288-91.

    PubMed 2009044
  • Van Den Houte M, Vlemincx E, Franssen M, Van Diest I, Van Oudenhove L, Luminet O. The respiratory occlusion discrimination task: A new paradigm to measure respiratory interoceptive accuracy. Psychophysiology. 2021 Apr;58(4):e13760. doi: 10.1111/psyp.13760. Epub 2021 Jan 12.

    PubMed 33438245
  • Bogaerts K, Walentynowicz M, Van Den Houte M, Constantinou E, Van den Bergh O. The Interoceptive Sensitivity and Attention Questionnaire: Evaluating Aspects of Self-Reported Interoception in Patients With Persistent Somatic Symptoms, Stress-Related Syndromes, and Healthy Controls. Psychosom Med. 2022 Feb-Mar 01;84(2):251-260. doi: 10.1097/PSY.0000000000001038.

    PubMed 34840287
  • Vlemincx E, Walentynowicz M, Zamariola G, Van Oudenhove L, Luminet O. A novel self-report scale of interoception: the three-domain interoceptive sensations questionnaire (THISQ). Psychol Health. 2023 Sep-Oct;38(9):1234-1253. doi: 10.1080/08870446.2021.2009479. Epub 2021 Dec 7.

    PubMed 34875958

Questions about this trial

What is this clinical trial studying?

An observational study of Fibromyalgia, run by Hasselt University at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Indra Ramakers (+32483082723, indra.ramakers@uhasselt.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Interoceptive accuracy (time frame: 20 minutes). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05907590, which also lists 23 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in